David Hevia

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

TXNIP upregulation controls metabolism and cell cycle during androgen deprivation therapy in prostate cancer.

TXNIP upregulation controls metabolism and cell cycle during androgen deprivation therapy in prostate cancer.

Journal: Cell death & disease

Published: February 20, 2025

Interplay between oxidative stress, neuroinflammatory cytokines and melatonin in Alzheimer's disease: Insights from cerebrospinal fluid analysis.

Interplay between oxidative stress, neuroinflammatory cytokines and melatonin in Alzheimer's disease: Insights from cerebrospinal fluid analysis.

Journal: Heliyon

Published: July 31, 2024

Castration promotes the browning of the prostate tumor microenvironment.

Castration promotes the browning of the prostate tumor microenvironment.

Journal: Cell communication and signaling : CCS

Published: June 27, 2023

Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase.

Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase.

Journal: Antioxidants (Basel, Switzerland)

Published: December 31, 2021

Melatonin Uptake by Cells: An Answer to Its Relationship with Glucose?

Melatonin Uptake by Cells: An Answer to Its Relationship with Glucose?

Journal: Molecules (Basel, Switzerland)

Published: July 03, 2018

GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress.

GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress.

Journal: Redox biology

Published: February 22, 2018

Melatonin transport into mitochondria.

Melatonin transport into mitochondria.

Journal: Cellular and molecular life sciences : CMLS

Published: July 14, 2017

Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study.

Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study.

Journal: International journal of molecular sciences

Published: July 02, 2017

The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?

The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?

Journal: International journal of cancer

Published: June 28, 2017

Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells.

Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells.

Journal: Redox biology

Published: December 20, 2016

Proanthocyanidin Characterization and Bioactivity of Extracts from Different Parts of Uncaria tomentosa L. (Cat's Claw).

Proanthocyanidin Characterization and Bioactivity of Extracts from Different Parts of Uncaria tomentosa L. (Cat's Claw).

Journal: Antioxidants (Basel, Switzerland)

Published: November 27, 2016

IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.

IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.

Journal: Journal of pineal research

Published: August 09, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026